BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8888048)

  • 1. Prognostic clues and outcome of early treatment of nonketotic hyperglycinemia.
    Boneh A; Degani Y; Harari M
    Pediatr Neurol; 1996 Sep; 15(2):137-41. PubMed ID: 8888048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketamine and strychnine treatment of an infant with nonketotic hyperglycinaemia.
    Tegtmeyer-Metzdorf H; Roth B; Günther M; Theisohn M; Heinemann U; Adams HA; Sticht G
    Eur J Pediatr; 1995 Aug; 154(8):649-53. PubMed ID: 7588967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neonatal form of a nonketotic hyperglycinemia in consanguinous parents].
    Plöchl E; Rittinger O; Doringer E; Laubichler W
    Klin Padiatr; 1991; 203(6):455-7. PubMed ID: 1758150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of benzoate in the management of seizures in nonketotic hyperglycinemia.
    Wolff JA; Kulovich S; Yu AL; Qiao CN; Nyhan WL
    Am J Dis Child; 1986 Jun; 140(6):596-602. PubMed ID: 3706242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dextromethorphan and high-dose benzoate therapy for nonketotic hyperglycinemia in an infant.
    Hamosh A; McDonald JW; Valle D; Francomano CA; Niedermeyer E; Johnston MV
    J Pediatr; 1992 Jul; 121(1):131-5. PubMed ID: 1385627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early treatment of severe infantile glycine encephalopathy (nonketotic hyperglycinemia) with strychnine and sodium benzoate.
    Melançon SB; Dallaire L; Vincelette P; Potier M; Geoffroy G
    Prog Clin Biol Res; 1979; 34():217-29. PubMed ID: 531053
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term use of high-dose benzoate and dextromethorphan for the treatment of nonketotic hyperglycinemia.
    Hamosh A; Maher JF; Bellus GA; Rasmussen SA; Johnston MV
    J Pediatr; 1998 Apr; 132(4):709-13. PubMed ID: 9580775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poor outcome for neonatal-type nonketotic hyperglycinemia treated with high-dose sodium benzoate and dextromethorphan.
    Chien YH; Hsu CC; Huang A; Chou SP; Lu FL; Lee WT; Hwu WL
    J Child Neurol; 2004 Jan; 19(1):39-42. PubMed ID: 15032382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dextromethorphan in a child with nonketotic hyperglycinaemia--a 6-year follow up.
    Schmitt B; Steinmann B
    Eur J Pediatr; 1998 Apr; 157(4):349-50. PubMed ID: 9578977
    [No Abstract]   [Full Text] [Related]  

  • 10. Transient neonatal hyperglycinemia.
    Schiffmann R; Kaye EM; Willis JK; Africk D; Ampola M
    Ann Neurol; 1989 Feb; 25(2):201-3. PubMed ID: 2919871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid glycine in nonketotic hyperglycinemic: effect of treatment with sodium benzoate and a ventricular shunt.
    Krieger I; Winbaum ES; Eisenbrey AB
    Metabolism; 1977 May; 26(5):517-24. PubMed ID: 850482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo 1H magnetic resonance spectroscopic measurement of brain glycine levels in nonketotic hyperglycinemia.
    Gabis L; Parton P; Roche P; Lenn N; Tudorica A; Huang W
    J Neuroimaging; 2001 Apr; 11(2):209-11. PubMed ID: 11296595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pitfalls in the diagnosis of glycine encephalopathy (non-ketotic hyperglycinemia).
    Korman SH; Gutman A
    Dev Med Child Neurol; 2002 Oct; 44(10):712-20. PubMed ID: 12418798
    [No Abstract]   [Full Text] [Related]  

  • 14. Nonketotic hyperglycinemia. Glycine accumulation due to absence of glycerine cleavage in brain.
    Perry TL; Urquhart N; MacLean J; Evans ME; Hansen S; Davidson GF; Applegarth DA; MacLeod PJ; Lock JE
    N Engl J Med; 1975 Jun; 292(24):1269-73. PubMed ID: 1128590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of early dextromethorphan and sodium benzoate therapy in an infant with nonketotic hyperglycinemia.
    Zammarchi E; Donati MA; Ciani F; Pasquini E; Pela I; Fiorini P
    Neuropediatrics; 1994 Oct; 25(5):274-6. PubMed ID: 7885541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical progress of neonatal non-ketotic hyperglycinemia under treatment].
    García-Pérez A; Martínez-Granero MA; Martín-Ancel AM; Bonet-Serra B; García-Muñoz MJ; García-Segura JM; Viaño J; Lama-More RA
    Rev Neurol; 2004 Oct 16-31; 39(8):727-30. PubMed ID: 15514900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal glycine encephalopathy: biochemical and neuropathologic findings.
    Agamanolis DP; Potter JL; Lundgren DW
    Pediatr Neurol; 1993; 9(2):140-3. PubMed ID: 8499044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonketotic hyperglycinemia: treatment with NMDA antagonist and consideration of neuropathogenesis.
    Ohya Y; Ochi N; Mizutani N; Hayakawa C; Watanabe K
    Pediatr Neurol; 1991; 7(1):65-8. PubMed ID: 1827585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzoate treatment and the glycine index in nonketotic hyperglycinaemia.
    Van Hove JL; Vande Kerckhove K; Hennermann JB; Mahieu V; Declercq P; Mertens S; De Becker M; Kishnani PS; Jaeken J
    J Inherit Metab Dis; 2005; 28(5):651-63. PubMed ID: 16151895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonketotic hyperglycinemia in a newborn infant.
    Tekinalp G; Coşkun T; Oran O; Ozalp I; Figen G; Ergin H
    Turk J Pediatr; 1995; 37(1):57-60. PubMed ID: 7732609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.